Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1996 1
1998 1
2000 3
2001 2
2002 5
2003 1
2004 3
2005 6
2006 10
2007 4
2008 6
2009 6
2010 4
2011 13
2012 15
2013 15
2014 24
2015 35
2016 51
2017 38
2018 52
2019 59
2020 78
2021 95
2022 110
2023 97
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

668 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
Tomás CC, Oliveira E, Sousa D, Uba-Chupel M, Furtado G, Rocha C, Teixeira A, Ferreira P, Alves C, Gisin S, Catarino E, Carvalho N, Coucelo T, Bonfim L, Silva C, Franco D, González JA, Jardim HG, Silva R, Baixinho CL, Presado MªH, Marques MªF, Cardoso ME, Cunha M, Mendes J, Xavier A, Galhardo A, Couto M, Frade JG, Nunes C, Mesquita JR, Nascimento MS, Gonçalves G, Castro C, Mártires A, Monteiro MªJ, Rainho C, Caballero FP, Monago FM, Guerrero JT, Monago RM, Trigo AP, Gutierrez ML, Milanés GM, Reina MG, Villanueva AG, Piñero AS, Aliseda IR, Ramirez FB, Ribeiro A, Quelhas A, Manso C, Caballero FP, Guerrero JT, Monago FM, Santos RB, Jimenez NR, Nuñez CG, Gomez IR, Fernandez MªJL, Marquez LA, Moreno AL, Huertas MªJT, Ramirez FB, Seabra D, Salvador MªC, Braga L, Parreira P, Salgueiro-Oliveira A, Arreguy-Sena C, Oliveira BF, Henriques MªA, Santos J, Lebre S, Marques A, Festas C, Rodrigues S, Ribeiro A, Lumini J, Figueiredo AG, Hernandez-Martinez FJ, Campi L, Quintana-Montesdeoca MªP, Jimenez-Diaz JF, Rodriguez-De-Vera BC, Parente A, Mata MªA, Pereira AMª, Fernandes A, Brás M, Pinto MªR, Parreira P, Basto ML, Rei AC, Mónico LM, Sousa G, Morna C, Freitas O, Freitas G, Jardim A, Vasconcelos … See abstract for full author list ➔ Tomás CC, et al. BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5. BMC Health Serv Res. 2016. PMID: 27409075 Free PMC article.
Maia, Michelle T. Oliveira, Anderson R. Sousa, Paulo P. Ferreira, Luci S. Lopes, Eujcely C. Santiago O45 Community Health screenings and self-reported chronic diseases Silvia Monteiro, Angelo Jesus, Armanda Colaco, Antonio Carvalho, Rita P. Silva, Agos …
Maia, Michelle T. Oliveira, Anderson R. Sousa, Paulo P. Ferreira, Luci S. Lopes, Eujcely C. Santiago O45 Community Health scre …
Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial.
D'Silva A, Marshall DA, Vallance JK, Nasser Y, Rajagopalan V, Szostakiwskyj JH, Raman M. D'Silva A, et al. Am J Gastroenterol. 2023 Feb 1;118(2):329-337. doi: 10.14309/ajg.0000000000002052. Epub 2022 Oct 11. Am J Gastroenterol. 2023. PMID: 36422517 Free PMC article. Clinical Trial.
IBS-SSS decreased significantly in the treatment group (delta change = 54.7, P = 0.028), but not in the control group (delta change = 22.6, P = 0.277). Fourteen patients (37%) in the yoga group reached a clinically relevant decrease of 50 points on the IBS-SSS posti …
IBS-SSS decreased significantly in the treatment group (delta change = 54.7, P = 0.028), but not in the control group (delta change = …
Experimental Entomology in the Age of Video.
Friedman DA, Wexler JR, Alvarado S. Friedman DA, et al. J Vis Exp. 2023 Feb 10;(192). doi: 10.3791/65002. J Vis Exp. 2023. PMID: 37602842
Journal of Visualized Experiments. (169), e62316 (2022). Topitzhofer, E., Lucas, H., Carlson, E., Chakrabarti, P., Sagili, R. Collection and identification of pollen from honey bee colonies. Journal of Visualized Experiments. (167), e62064 (2022). Nogueira, B. R …
Journal of Visualized Experiments. (169), e62316 (2022). Topitzhofer, E., Lucas, H., Carlson, E., Chakrabarti, P., Sagili, R. …
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
The mean MDS-UPDRS total score at baseline was 34.3 in the deferiprone group and 33.2 in the placebo group and increased (worsened) by 15.6 points and 6.3 points, respectively (difference, 9.3 points; 95% confidence interval, 6.3 to 12.2; P<0.001). Nigrostriatal iron co …
The mean MDS-UPDRS total score at baseline was 34.3 in the deferiprone group and 33.2 in the placebo group and increased (worsened) by 15.6 …
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.
Boers M, Hartman L, Opris-Belinski D, Bos R, Kok MR, Da Silva JA, Griep EN, Klaasen R, Allaart CF, Baudoin P, Raterman HG, Szekanecz Z, Buttgereit F, Masaryk P, Klausch LT, Paolino S, Schilder AM, Lems WF, Cutolo M; GLORIA Trial consortium. Boers M, et al. Ann Rheum Dis. 2022 Jul;81(7):925-936. doi: 10.1136/annrheumdis-2021-221957. Epub 2022 May 31. Ann Rheum Dis. 2022. PMID: 35641125 Free PMC article. Clinical Trial.
Disease activity was 0.37 points lower on prednisolone (95% CL 0.23, p<0.0001); joint damage progression was 1.7 points lower (95% CL 0.7, p=0.003). 60% versus 49% of patients experienced the harm outcome, adjusted relative risk 1.24 (95% CL 1.04, p=0.02), …
Disease activity was 0.37 points lower on prednisolone (95% CL 0.23, p<0.0001); joint damage progression was 1.7 points lower (95% …
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
Guimarães HP, Lopes RD, de Barros E Silva PGM, Liporace IL, Sampaio RO, Tarasoutchi F, Hoffmann-Filho CR, de Lemos Soares Patriota R, Leiria TLL, Lamprea D, Precoma DB, Atik FA, Silveira FS, Farias FR, Barreto DO, Almeida AP, Zilli AC, de Souza Neto JD, Cavalcante MA, Figueira FAMS, Kojima FCS, Damiani L, Santos RHN, Valeis N, Campos VB, Saraiva JFK, Fonseca FH, Pinto IM, Magalhães CC, Ferreira JFM, Alexander JH, Pavanello R, Cavalcanti AB, Berwanger O; RIVER Trial Investigators. Guimarães HP, et al. N Engl J Med. 2020 Nov 26;383(22):2117-2126. doi: 10.1056/NEJMoa2029603. Epub 2020 Nov 14. N Engl J Med. 2020. PMID: 33196155 Clinical Trial.
A primary-outcome event occurred at a mean of 347.5 days in the rivaroxaban group and 340.1 days in the warfarin group (difference calculated as restricted mean survival time, 7.4 days; 95% confidence interval [CI], -1.4 to 16.3; P<0.001 for noninferiority). Death from …
A primary-outcome event occurred at a mean of 347.5 days in the rivaroxaban group and 340.1 days in the warfarin group (difference calculate …
Retracted: 'The effects of Duchenne muscular dystrophy on the performance of the stomatognathic system: case-control study', by Ferreira B., Da Silva G.P., Goncalves C.R., et al.
[No authors listed] [No authors listed] Dev Med Child Neurol. 2016 May;58(5):523. doi: 10.1111/dmcn.12707. Epub 2015 Feb 13. Dev Med Child Neurol. 2016. PMID: 25683793 Free article.
The retraction has been made due to concerns relating to the validity of the EMG methodology and its interpretation, which affect the results of the paper. Reference Ferreira B, Da Silva GP, Goncalves CR, Arnoni VW, Siessere S, Semprini M, Verri ED, Chaves TC, Regal …
The retraction has been made due to concerns relating to the validity of the EMG methodology and its interpretation, which affect the result …
Single High Dose of Liposomal Amphotericin B in Human Immunodeficiency Virus/AIDS-Related Disseminated Histoplasmosis: A Randomized Trial.
Pasqualotto AC, Lana DD, Godoy CSM, Leitão TDMJS, Bay MB, Damasceno LS, Soares RBA, Kist R, Silva LR, Wiltgen D, Melo M, Guimarães TF, Guimarães MR, Vechi HT, de Mesquita JRL, Monteiro GRG, Adenis A, Bahr NC, Spec A, Boulware DR, Israelski D, Chiller T, Falci DR. Pasqualotto AC, et al. Clin Infect Dis. 2023 Oct 13;77(8):1126-1132. doi: 10.1093/cid/ciad313. Clin Infect Dis. 2023. PMID: 37232940 Free PMC article. Clinical Trial.
Day 14 clinical response was 84% for single-dose L-AmB, 69% 2-dose L-AmB, and 74% for control arm (P = .69). Overall survival on D14 was 89.0% (34/38) for single-dose L-AmB, 78.0% (29/37) for 2-dose L-AmB, and 92.1% (35/38) for control arm (P = .82). ...
Day 14 clinical response was 84% for single-dose L-AmB, 69% 2-dose L-AmB, and 74% for control arm (P = .69). Overall survival on D14 …
Urinary metabolomic biomarker candidates for skeletal muscle wasting in patients with rheumatoid arthritis.
Oliveira MS, Santo RCE, Silva JMS, Alabarse PVG, Brenol CV, Young SP, Xavier RM. Oliveira MS, et al. J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1657-1669. doi: 10.1002/jcsm.13240. Epub 2023 May 26. J Cachexia Sarcopenia Muscle. 2023. PMID: 37243418 Free PMC article.
Principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were applied to the (1) H-NMR data, followed by Spearman's correlation analysis. ...Fifteen metabolites were identified in the urine samples with high variable importance in project …
Principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were applied to the (1) H-NMR data, follo …
Vascular function in asthmatic children and adolescents.
Augusto LS, Silva GC, Pinho JF, Aires RD, Lemos VS, Ramalho LF, Jentzsch NS, Rodrigues-Machado MG. Augusto LS, et al. Respir Res. 2017 Jan 17;18(1):17. doi: 10.1186/s12931-016-0488-3. Respir Res. 2017. PMID: 28095859 Free PMC article.
In the control group, the LnRHI correlated positively with baseline systolic blood pressure (r = 0.53, p = 0.02) and mean arterial pressure (r = 0.50, p = 0.03), age (r = 0.61, p = 0.007), weight (r = 0.63, p = 0.004) and he …
In the control group, the LnRHI correlated positively with baseline systolic blood pressure (r = 0.53, p = 0.02) and mean arte …
668 results